Departamento de Biología, Facultad de Ciencias, Universidad de Chile, Santiago, Chile.
Facultad de Medicina y Ciencia, Universidad San Sebastián, Santiago, Chile.
Mol Biol Rep. 2022 Jun;49(6):4193-4204. doi: 10.1007/s11033-022-07252-0. Epub 2022 Feb 24.
Several studies have demonstrated the contribution of innate immune cells, including macrophages, in promoting systemic lupus erythematosus (SLE). Macrophages, one of the most abundant cell populations in the peritoneal cavity, are considered multifunctional cells with phenotypic plasticity. However, the functional properties of peritoneal macrophages in steady-state and during the progression of SLE remain poorly defined.
Using the [NZB × NZW]F1 (BWF1) murine model of SLE, we analyzed the phenotype and function of peritoneal macrophages during the disease's onset. We found a higher frequency of peritoneal macrophages and B1a cells in BWF1-diseased mice than age-matched controls. Additionally, macrophages from diseased animals expressed lower levels of CD206, MHC-II, and Sirpα. RNAseq analysis identified 286 differentially expressed genes in peritoneal macrophages from diseased-BWF1 mice compared to control mice. Functional experiments demonstrate that peritoneal macrophages from diseased-BWF1 mice secrete higher levels of pro-inflammatory cytokines when activated with TLR7 and TLR9 agonists, and they were less efficient in suppressing the activation and proliferation of peritoneal LPS-activated B cells. These data demonstrate that peritoneal macrophages from BWF1-diseased mice present phenotypic and functional alterations shifting to a more pro-inflammatory state.
The increase of macrophages with an altered phenotype and function together with the accumulation of B1a cells in the peritoneal cavity of diseased-BWF1 mice may promote the progression of the disease. Advancing awareness of the role and phenotype of peritoneal macrophages in SLE may contribute to a better understanding of these types of diseases and the development of novel therapies.
多项研究表明,固有免疫细胞(包括巨噬细胞)在促进系统性红斑狼疮(SLE)中发挥作用。巨噬细胞是腹腔中最丰富的细胞群体之一,被认为是具有表型可塑性的多功能细胞。然而,在稳态和 SLE 进展过程中腹腔巨噬细胞的功能特性仍未得到明确界定。
我们使用 SLE 的 [NZB × NZW]F1(BWF1)小鼠模型,分析了疾病发作期间腹腔巨噬细胞的表型和功能。我们发现 BWF1 患病小鼠的腹腔巨噬细胞和 B1a 细胞频率高于同龄对照。此外,患病动物的巨噬细胞表达的 CD206、MHC-II 和 Sirpα 水平较低。RNAseq 分析鉴定出与对照小鼠相比,患病-BWF1 小鼠腹腔巨噬细胞中有 286 个差异表达基因。功能实验表明,当用 TLR7 和 TLR9 激动剂激活时,来自患病-BWF1 小鼠的腹腔巨噬细胞会分泌更高水平的促炎细胞因子,并且它们在抑制腹腔 LPS 激活的 B 细胞的激活和增殖方面效率较低。这些数据表明,来自患病-BWF1 小鼠的腹腔巨噬细胞表现出表型和功能改变,向更促炎状态转变。
患病-BWF1 小鼠腹腔中具有改变表型和功能的巨噬细胞增加以及 B1a 细胞的积累可能会促进疾病的进展。提高对 SLE 中腹腔巨噬细胞的作用和表型的认识,可能有助于更好地理解这些类型的疾病,并开发新的治疗方法。